Wednesday, May 8, 2024

Partner Profiles

Global collaboration announced to develop seralutinib for pulmonary hypertension

Chiesi Farmaceutici and Gossamer Bio Inc have entered into a global collaboration to develop seralutinib for pulmonary hypertension treatment.
ARM-002TM vaccine shows effectiveness against pancreatic cancer

Trial demonstrates ARM-002TM vaccine’s effectiveness against pancreatic cancer

Defence Therapeutics has announced a successful pre-clinical vaccination trial utilising its ARM-002TM vaccine against pancreatic cancer.
anti-cancer vaccine

ARM-002TM anti-cancer vaccine shows promise in combatting pre-established melanoma

Defence Therapeutics Inc. has unveiled the exceptional efficacy of its second-generation ARMTM anti-cancer vaccine. The anti-cancer vaccine, dubbed ARM-002TM, has demonstrated proficiency in combating pre-established...


Pin It on Pinterest